<DOC>
	<DOCNO>NCT01080560</DOCNO>
	<brief_summary>To demonstrate bioequivalence Test Product ( A ) : Cyclosporine Soft Gelatin Capsules Modified 100 mg manufacture Panacea Biotec Ltd , India correspond Reference Product ( B ) : Neoral ( Cyclosporine capsule , USP ) Modified 100mg manufactured Novartis Pharmaceuticals Corporation , New Jersey , 36 healthy adult male subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Cyclosporine 100mg Capsule Under Fasting Condition</brief_title>
	<detailed_description>Total 36 normal healthy adult male subject enrol study . Subjects administer either Test Reference Product 240 mL water period per randomization schedule . Subjects fast least 10 hour prior dose administration least 4 hour post dose . Standardized meal provide study period . Water accessible subject 1 hour Predose 2 hour Post dose period . A total 24 blood sample withdraw pharmacokinetic profiling . The whole blood concentration Cyclosporine measure validated LC/MS/MS analytical method . Ratio analysis perform untransformed log transform pharmacokinetic parameter Cmax , AUC0-72 , AUC0 inf . ANOVA perform log transform pharmacokinetic parameter Cmax , AUC0-72 , AUC0-inf 90 % confidence interval construct ratio geometric least square mean Test Reference product , obtain log-transformed data . Bioequivalence conclude ratio estimate well 90 % confidence interval , fall within acceptable range 80.00 % 125.00 % Cmax , AUC0-72 AUC0-inf .</detailed_description>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>1 . Male subject range 18 45 year age . 2 . The healthy human subject , whose body weight within Â± 15 % ideal weight relate height body frame accord Life Insurance Corporation ( LIC ) Chart ( Appendix A ) . 3 . Subjects normal finding determine baseline history , physical examination vital sign ( blood pressure , pulse rate body temperature ) . 4 . Subjects normal finding determine hematological test , Serum Chemistry , serological test , urine analysis , ECG Xray ( Xray take ) . 5 . Willingness follow protocol requirement evidence write , informed consent . 6 . Agreeing , use medication ( either prescribed , OTC alternate medicine ) , include vitamin mineral 14 day prior study course study . 7 . No history presence significant alcoholism drug abuse past one year . 8 . Nonsmokers , ex smoker light smoker include . `` Light smoker define someone smoking 10 cigarette less per day , ex smoker someone completely stop smoke least 3 month . 1 . Requiring medication ailment include enzymemodifying drug previous 28 day , day one ( 1 ) . 2 . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . 3 . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic psychiatric disease . 4 . Subjects history recent myocardial infarction , cardiac arrhythmia , cardiac failure convulsion . 5 . Participation clinical drug study bioequivalence study 90 day prior present study . 6 . History malignancy serious disease . 7 . Refusal abstain food least ten ( 10.00 ) hour prior drug administration least four ( 04.00 ) hour post dose . 8 . Refusal abstain water least one ( 01.00 ) hour prior study drug administration first day study period least two ( 02.00 ) hour post dose . 9 . Any contraindication blood sampling . 10 . Refusal abstain smoke consumption tobacco product 48.00 hour dose last sample collection period . 11 . Found positive Breath alcohol test do time check study period . 12 . History drug abuse past one year . 13 . Use xanthinecontaining beverage food , grape fruit juice 48.00 hour prior drug dose . 14 . Blood donation 90 day prior commencement study . 15 . Subjects positive HBsAg HepatitisC test HIV test Anti Treponema Palladium/Syphilis test . 16 . Known history hypersensitivity Cyclosporine component formulation .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Bioequivalence study healthy volunteer</keyword>
</DOC>